Copper Storage Disease in Dogs: Our Integrative Approach
Dr Matthew J Muir - Clinical Director All Natural Vet Care
Copper storage disease, also known as copper-associated hepatopathy, occurs when excessive copper accumulates within the liver. Over time, this can damage liver cells, promote inflammation and contribute to fibrosis or scarring.
Some dogs develop copper accumulation because of an inherited susceptibility, while others may be affected by dietary exposure, impaired copper excretion or a combination of factors. Although certain breeds are recognised as being at greater risk, copper-associated liver disease can occur in almost any dog.
At All Natural Vet Care, our aim is to reduce ongoing liver injury while supporting the whole patient. Treatment is individualised according to the degree of copper accumulation, liver biopsy findings, blood results, symptoms, concurrent disease, medication tolerance and the family’s preferences.
Diagnosis: more than an elevated ALT
Copper-associated liver disease is often first suspected when a dog has persistently elevated liver enzymes, particularly ALT. However, ALT is a marker of liver-cell injury rather than a direct measurement of copper or fibrosis.
A complete assessment may include:
repeated liver blood tests;
abdominal ultrasound;
bile acids or other liver-function testing;
infectious-disease screening where appropriate;
assessment of medications, supplements and diet;
liver biopsy with histopathology;
quantitative hepatic copper measurement.
A biopsy can help determine not only how much copper is present, but also whether there is active inflammation, cell death, fibrosis, cirrhosis or another underlying liver disorder.
Ultrasound remains valuable, but it cannot reliably exclude early copper accumulation or accurately grade mild fibrosis.
Treatment is guided by disease severity
There is no single protocol that suits every dog.
A dog with severe inflammation, marked copper accumulation or progressive liver dysfunction may require more intensive treatment than a clinically well dog with mild fibrosis and preserved liver function.
Our treatment priorities generally include:
reducing further copper absorption;
removing stored copper when necessary;
protecting liver cells;
reducing inflammation and fibrosis risk;
maintaining appetite, gastrointestinal tolerance and quality of life;
monitoring response objectively.
Copper chelation
Chelating medications bind copper and help remove it from the body. D-penicillamine is commonly used and can be highly valuable, particularly when hepatic copper concentrations are substantial or liver inflammation is active.
However, some dogs experience adverse effects such as:
nausea;
vomiting;
diarrhoea;
reduced appetite;
food aversion.
In those patients, we may adjust the dose, introduce it more gradually, change administration timing or consider an alternative chelator such as trientine.
Chelation remains one of the most direct methods of lowering stored hepatic copper, but treatment must be tolerable. A protocol that causes persistent anorexia or significant gastrointestinal disease may undermine the dog’s broader recovery.
Therapeutic copper restriction
Diet is central to long-term management.
For dogs with clinically relevant hepatic copper accumulation, we generally aim for a diet containing less than approximately:
0.12 mg copper per 100 kcal, or 1.2 mg copper per 1,000 kcal.
This usually requires more than simply avoiding liver.
Potential copper sources include:
liver and other organ meats;
shellfish;
some mineral premixes;
copper-fortified pet foods;
certain chelated copper supplements;
unanalysed raw or homemade diets.
The total copper concentration must be considered in relation to calorie intake. A food can appear low in copper on a dry-matter basis yet still provide excessive copper if the dog must eat a large amount to meet energy needs.
Our whole-food formulation approach
Where appropriate, we, or a board-certified veterinary nutritionist colleague, formulate carefully controlled whole-food diets using low-copper ingredients such as selected whitefish, grains and low-copper fruit and vegetables.
A therapeutic homemade diet must still provide sufficient:
protein;
calories;
calcium and phosphorus;
zinc;
iodine;
essential fatty acids;
other vitamins and trace minerals.
Copper restriction should not create a different nutritional deficiency.
We often use a copper-free veterinary nutrient balancer as part of the formulation. Although these products contain purified vitamins and minerals, they provide nutrients that can be difficult to supply consistently through food alone, particularly in a tightly restricted therapeutic diet.
Our preference is to combine nutritional precision with a broad food matrix. This may include:
carefully selected protein sources;
fermentable fibre;
low-copper vegetable diversity;
omega-3 fatty acids;
carotenoids and polyphenols;
targeted nutrients only where needed.
Homemade therapeutic diets are monitored clinically and should be reviewed periodically for body weight, muscle condition, ingredient substitutions, recipe drift and estimated nutrient adequacy.
The role of zinc
Zinc can help reduce intestinal copper absorption by stimulating metallothionein within the intestinal lining. Copper binds to metallothionein and is then lost when intestinal cells are naturally shed.
Zinc therefore works differently from chelation:
Chelators help remove copper already stored in the body.
Zinc primarily helps reduce absorption of new dietary copper.
Therapeutic zinc doses can be considerably higher than ordinary nutritional supplementation. We individualise the starting dose because zinc can also cause nausea, vomiting or reduced appetite.
In dogs with gastrointestinal sensitivity, we may:
start below the full therapeutic dose;
increase gradually;
give it with a small amount of food initially;
separate it from calcium, iron and mineral-containing meals where practical;
monitor plasma zinc and the complete blood count.
The aim is not simply to give the highest possible dose. It is to achieve a useful and tolerable level while avoiding deficiency or excess.
Liver-supportive supplements
Depending on the individual dog, we may consider selected hepatoprotective nutrients or herbs.
SAMe
S-adenosylmethionine supports hepatic glutathione metabolism and cellular antioxidant defence. Product quality, dose and administration timing matter because oral bioavailability varies.
Milk thistle
Milk thistle extracts provide silymarin compounds, including silybin. These are used for their antioxidant, hepatoprotective and potentially antifibrotic effects.
Vitamin E
Vitamin E may be useful where oxidative stress is contributing to liver-cell injury. It should be dosed appropriately rather than added indiscriminately.
Omega-3 fatty acids
EPA and DHA may support inflammatory regulation and broader cardiovascular, renal, neurological and joint health. Their inclusion must be balanced against total dietary fat and any history of pancreatitis or fat intolerance.
Ursodeoxycholic Acid
Ursodeoxycholic acid, also called ursodiol or UDCA, is a prescription bile acid that may be considered in selected dogs with copper-associated hepatopathy. It can support bile flow, replace more potentially damaging bile acids and may have hepatoprotective, anti-inflammatory and antifibrotic effects.
UDCA does not chelate copper or reliably remove copper already stored in the liver. It is therefore used as an adjunct rather than a substitute for dietary copper restriction, zinc or chelation when chelation is indicated.
Herbal medicine
Herbs such as schisandra, dandelion, artichoke and selected traditional formulas may be considered, but they should be integrated carefully rather than layered together without a clear rationale.
Please Note: liver detoxification is not the same as treating copper accumulation.
Supporting the gut–liver axis
The intestine influences bile-acid metabolism, immune signalling and the absorption and excretion of minerals.
The microbiome may also influence copper handling, although this area is not yet sufficiently understood to justify strong claims.
We may support gastrointestinal resilience through:
gradual dietary transitions;
appropriate fibre diversity;
selected prebiotics or probiotics;
management of nausea and food aversion;
avoiding unnecessary supplement overload;
addressing concurrent pancreatic or intestinal disease.
Maintaining appetite and normal stool quality is not a secondary concern. It is essential to successful long-term liver treatment.
We may elect microbiome testing, faecal microbiome transplantation or probiotics as part of our individualised care.
Monitoring response
ALT is useful for monitoring hepatocellular injury, but it does not directly measure hepatic copper or fibrosis.
We usually interpret ALT alongside:
AST, ALP and GGT;
bilirubin;
albumin;
cholesterol;
glucose;
complete blood count;
kidney parameters;
urinalysis;
clinical signs;
body and muscle condition;
appetite and stool quality.
Depending on the protocol, blood tests may be repeated every two to three months during the initial treatment phase.
Plasma zinc may be added when therapeutic zinc is being used.
Repeat ultrasound can assess liver architecture, the biliary system, portal vasculature and other abdominal organs, but it cannot precisely quantify mild fibrosis.
In some cases, repeat liver biopsy may provide the clearest assessment of copper depletion. However, this must be weighed against age, invasiveness, cost and whether the result would meaningfully change management.
What improvement looks like
Our initial goals may include:
normal appetite;
stable gastrointestinal function;
consistent adherence to a copper-restricted diet;
reduction in ALT;
preserved albumin and bilirubin;
stable body weight and muscle mass;
no evidence of progressive liver dysfunction.
Normalisation of ALT is ideal, but it may take time. A meaningful early reduction can still indicate that the overall strategy is helping.
If liver enzymes remain static or rise despite good dietary adherence, we reconsider the diagnosis, copper-control strategy and need for chelation or specialist reassessment.
Prognosis
Prognosis depends heavily on the stage at diagnosis.
Dogs with mild fibrosis, preserved liver function and minimal inflammation often have a much more favourable outlook than dogs presenting with cirrhosis, jaundice, low albumin, ascites or hepatic encephalopathy.
Early diagnosis gives us an opportunity to intervene before irreversible liver failure develops.
However, copper-associated hepatopathy is usually a long-term condition. Even when blood tests improve, ongoing dietary control and periodic monitoring remain important.
A coordinated, individualised approach
Our role is to combine conventional hepatology, therapeutic nutrition and integrative support without overstating what any one treatment can achieve.
For some dogs, chelation is essential. For others, a measured diet-first strategy may be appropriate. Many dogs benefit from a combination of:
copper restriction;
zinc;
liver-supportive nutrients;
gastrointestinal support;
targeted herbal medicine;
serial blood testing;
collaboration with local veterinarians and internal-medicine specialists.
The most successful plan is not necessarily the most aggressive one. It is the plan that is medically appropriate, nutritionally sound, tolerable for the dog and sustainable for the family.
Consultations and support
For clients in Australia: We provide veterinary telemedicine consultations where legally and clinically appropriate, working alongside your dog’s local veterinarian for physical examinations, diagnostic testing, prescriptions and urgent care.
For clients able to attend our Sydney practice: In-person integrative veterinary consultations are available at All Natural Vet Care.
For international clients: We offer naturopathic consultations focused on nutrition, supplements, herbal support and whole-patient wellbeing. These consultations do not replace care from your local veterinarian and cannot provide diagnosis, veterinary prescribing or emergency treatment in your country.
